Under the microscope: a good gut feeling
Gut microbiota is made up of all the micro-organisms (mainly bacteria) living in our intestines. There are thousands of species of bacteria that make up your gut microbiota, and everyone’s is different.
Working as a team
The relationship between you and your gut microbiota benefits everyone involved. The body provides a safe environment with a steady supply of nutrients for the microbes. In return, they help with digestion and so much more.
Gut microbiota can help to shape what immune cells are present in the body, and in what quantity. This can mean making the immune system more tolerant to good bacteria and better at fighting harmful bacteria.
Thinking from your stomach
What’s more, the gut microbiota can even affect the central nervous system. Molecules produced by microbes can cause nerves to send messages from the intestines to the brain. These effects depend on what microbes are present in the gut.
A growing body of data has implicated the gut microbiota in a wide range of conditions, including inflammatory bowel disease, cardiovascular disease and MS.
Small changes for great benefit
Researchers have found they can reduce the severity of a mouse-model of MS by changing the types of microbes present in the intestines of the mice. In August 2017 researchers found that a common gut bacterium, called P. histicola, can reduce MS-like symptoms in mice. The bacteria changed the behaviour of cells im the immune system, and how easy it was for them to get into the brain.
The effects extend beyond the immune system. A recent study has shown the gut microbiota can affect the process of adding myelin to nerves in mice. Mice without gut microbiota had thicker layers of myelin in their prefrontal cortex (a section of the brain).
A growing body of work
Whilst it is not known whether this is true in humans, it is evidence of the extent to which the microbiota can influence processes in the body.
So far, studies have looked for differences in the gut microbiota of people with MS compared to those without. These small-scale studies have found differences between these two groups, suggesting the gut microbiota could play a role in MS.
A much larger study, led by the MS Microbiome Consortium, is now underway.
What we know so far highlights the potential of using gut microbes or components of microbes as a treatment for MS. Understanding the changes in the microbiota in MS is the next step to see if treatments could be effective.
We look forward to seeing this area of research progress – but for now, we’re impressed at just how big an effect these little guys can have in the body.
We’re at the start of a generation of research delivering major advances in MS treatment and we need your help to keep up the momentum.